Growth Metrics

Nu-Med Plus (NUMD) Shareholder's Equity (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 52.06 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 22.98 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 49.20 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 26.10 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 10.33 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2.96 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.67 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 7.20 Bn
10 Nu-Med Plus - - - -271,278.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -271,278.00
Sep 30, 2025 -258,660.00
Jun 30, 2025 -246,694.00
Mar 31, 2025 -235,029.00
Dec 31, 2024 -215,096.00
Sep 30, 2024 -204,541.00
Jun 30, 2024 -185,864.00
Mar 31, 2024 -168,577.00
Dec 31, 2023 -146,751.00
Sep 30, 2023 -131,955.00
Jun 30, 2023 -115,549.00
Mar 31, 2023 -91,229.00
Dec 31, 2022 -63,025.00
Sep 30, 2022 -270,131.00
Jun 30, 2022 -247,081.00
Mar 31, 2022 -189,011.00
Dec 31, 2021 -132,358.00
Sep 30, 2021 -70,017.00
Jun 30, 2021 -1,651.00
Mar 31, 2021 190,955.00
Dec 31, 2020 467,703.00
Sep 30, 2020 221,675.00
Jun 30, 2020 411,587.00
Mar 31, 2020 -367,327.00
Dec 31, 2019 -370,432.00
Sep 30, 2019 -303,412.00
Jun 30, 2019 -307,254.00
Mar 31, 2019 -224,668.00
Dec 31, 2018 48,527.00
Sep 30, 2018 194,484.00
Jun 30, 2018 -24,829.00
Mar 31, 2018 -21,024.00
Dec 31, 2017 68,242.00
Sep 30, 2017 44,975.00
Jun 30, 2017 -96,997.00
Mar 31, 2017 -36,650.00
Dec 31, 2016 -4.44 Mn
Sep 30, 2016 -136,608.00
Jun 30, 2016 577,699.00
Mar 31, 2016 -253,786.00
Dec 31, 2015 -15.22 Mn
Sep 30, 2015 -216,005.00
Jun 30, 2015 -184,928.00
Mar 31, 2015 -175,950.00
Dec 31, 2014 -7.11 Mn
Sep 30, 2014 -53,766.00
Jun 30, 2014 284,427.00
Mar 31, 2014 244,059.00
Dec 31, 2013 -124,339.00
Sep 30, 2013 -145,695.00
Jun 30, 2013 -164,897.00
Mar 31, 2013 -128,742.00
Dec 31, 2012 -46,084.00
Dec 31, 2011 -294.00